35
Participants
Start Date
November 8, 2021
Primary Completion Date
March 11, 2025
Study Completion Date
March 11, 2025
Diazepam Nasal Spray [Valtoco]
5 mg, 10 mg, or 15 mg dose of intranasal VALTOCO will be administered based on the subject's body weight.
Boston Children's Health Physicians, Hawthorne
University of Rochester, Rochester
Children's Hospital of the King's Daughters, Norfolk
Duke University Hospital, Durham
Center for Rare Neurological Diseases, Norcross
Northwest Florida Clinical Research Group, LLC., Gulf Breeze
AdventHealth Research Institute, Orlando
Nicklaus Children's Hospital, Miami
Le Bonheur Children's Hospital, Memphis
University of Missouri Women & Children's Hospital, Columbia
UT Southwestern Medical Center, Dallas
Massachusetts General Hospital, Boston
Northeast Regional Epilepsy Group, Hackensack
Lead Sponsor
Neurelis, Inc.
INDUSTRY